Stem Cells and Regenerative Medicine : Volume III: Pharmacology and Therapy.

Stem Cells and Regenerative Medicine : Volume III: Pharmacology and Therapy.

Annotation.

Saved in:
Bibliographic Details
Main Author: Taupin, Phillippe
Format: eBook
Language:English
Published: Hauppauge : Nova Science Publishers, Incorporated, Jan. 2008.
Subjects:
Stem cells.
Regenerative medicine.
Regenerative medicine
Stem cells
Online Access:Click for online access
Table of Contents:
  • STEM CELLS AND REGENERATIVE MEDICINE, VOLUME III: PHARMACOLOGY AND THERAPY ; STEM CELLS AND REGENERATIVE MEDICINE, VOLUME III: PHARMACOLOGY AND THERAPY; CONTENTS; PREFACE ; INTRODUCTION ; REFERENCES ; NEUROGENESIS AND ALZHEIMER'S DISEASE; ABSTRACT ; 1. INTRODUCTION; 2. NEUROGENESIS IN ALZHEIMER'S DISEASE ; 3. EFFECT ON NEUROGENESIS OF DRUGS USED TO TREAT AD ; 4. STEM CELL THERAPY FOR THE TREATMENT OF AD ; 5. CONCLUSION; ACKNOWLEDGMENTS ; REFERENCES ; NEUROGENESIS AND THE EFFECT OF ANTIDEPRESSANTS ; ABSTRACT; 1. INTRODUCTION.
  • 2. NEUROGENESIS CONTRIBUTES TO THE THERAPEUTIC EFFECTS OF ANTIDEPRESSANTS 3. A NEUROGENIC THEORY OF DEPRESSION ; 4. CONCLUSION ; ACKNOWLEDGMENTS; REFERENCES; ADULT NEURAL STEM CELLS AND CELLULAR THERAPY; ABSTRACT ; 1. INTRODUCTION ; 2. ADULT NEUROGENESIS AND NEURAL STEM CELLS; 3. ADULT NEURAL STEM CELLS AND CELLULAR THERAPY; 4. ADULT NEURAL STEM CELLS: A MODEL OF CHOICE FOR CELLULAR THERAPY FOR CNS DISEASES AND INJURIES ; 5. CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; STEM CELL ENGINEERING FOR CELL-BASED THERAPY; ABSTRACT ; 1. INTRODUCTION.
  • 2. CELL ENGINEERING TO DERIVE ESCS WITHOUT THE DESTRUCTION OF EMBRYOS 3. ADULT NEURAL STEM CELL ENGINEERING ; 4. CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; HUCNS-SC STEM CELLS; SUMMARY ; ABSTRACT ; 1. INTRODUCTION ; 2. SYNTHESIS AND SAR; 3. PRECLINICAL DEVELOPMENT; 4. METABOLISM AND PHARMACOKINETICS ; 5. TOXICITY ; 6. CLINICAL DEVELOPMENT ; 7. SIDE EFFECTS AND CONTRAINDICATIONS ; 8. PATENT SUMMARY ; 9. CURRENT OPINION ; 10. LICENSING ; 11. DEVELOPMENT HISTORY ; 12. LITERATURE CLASSIFICATIONS ; 13. ASSOCIATED PATENT ; ACKNOWLEDGMENTS ; REFERENCES.
  • OTI-010 OSIRIS THERAPEUTICS/JCR PHARMACEUTICALS ABSTRACT ; 1. INTRODUCTION ; 2. SYNTHESIS AND SAR ; 3. PRECLINICAL DEVELOPMENT ; 4. METABOLISM AND PHARMACOKINETICS ; 5. TOXICITY ; 6. CLINICAL DEVELOPMENT ; 7. SIDE EFFECTS AND CONTRAINDICATIONS ; 8. PATENT SUMMARY ; 9. CURRENT OPINION ; 10. LICENSING ; 11. DEVELOPMENT HISTORY; 12. LITERATURE CLASSIFICATIONS ; 13. ASSOCIATED PATENT; ACKNOWLEDGMENTS ; REFERENCES ; ADA-TRANSDUCED HEMATOPOIETIC STEM CELL THERAPY FOR ADA-SCID ; SUMMARY ; ABSTRACT ; 1. INTRODUCTION ; 2. SYNTHESIS AND SAR ; 3. PRECLINICAL DEVELOPMENT.
  • 4. METABOLISM AND PHARMACOKINETICS 5. TOXICITY ; 6. CLINICAL DEVELOPMENT ; 7. SIDE EFFECTS AND CONTRAINDICATIONS ; 8. PATENT SUMMARY ; 9. CURRENT OPINION ; 10. DEVELOPMENT HISTORY ; 11. LITERATURE CLASSIFICATIONS ; ACKNOWLEDGMENTS ; REFERENCES ; THERAPEUTIC POTENTIAL OF ADULT NEURAL STEM CELLS; ABSTRACT; 1. INTRODUCTION ; 2. NEURAL PROGENITOR AND STEM CELLS; 3. THERAPEUTIC POTENTIAL OF ADULT NSCS; 4. CURRENT AND FUTURE DEVELOPMENTS; ACKNOWLEDGEMENTS ; REFERENCES ; CONCLUSION AND PERSPECTIVES: ADULT NEURAL STEM CELLS
  • THE PROMISE OF THE FUTURE; ABSTRACT ; 1. INTRODUCTION.

Similar Items